ஜப்பான் நீரிழிவு நோய் சமூகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜப்பான் நீரிழிவு நோய் சமூகம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜப்பான் நீரிழிவு நோய் சமூகம் Today - Breaking & Trending Today

Poxel Announces its Participation at the 64th Annual Meeting of the Japan Diabetes Society


Press release content from Business Wire. The AP news staff was not involved in its creation.
Poxel Announces its Participation at the 64th Annual Meeting of the Japan Diabetes Society
May 11, 2021 GMT
LYON, France (BUSINESS WIRE) May 11, 2021
POXEL SA (Euronext – POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH) today announced its participation at the 64 th Annual Meeting of the Japan Diabetes Society (May 20-22, 2021).
Three presentations on Imeglimin will be included in an oral session for large clinical studies in the afternoon (2:30 pm to 3:40 pm JST) of May 20. These presentations will be focused on the analysis and interpretation of clinical data derived from Phase 2 and Phase 3 (TIMES program) trials with Imeglimin, Poxel’s novel antidiabetic investigational drug, where Japanese patients with type 2 diabe ....

United States , South Korea , Sumitomo Dainippon Pharma , Arthur Rouill , Valeria Fisher , Catherine David , World Health Organization , Meeting Of The Japan Diabetes Society , Devices Agency , Trophic Communications , Annual Meeting , Japan Diabetes Society , Long Term Phase , Southeast Asian , Medical Devices Agency , Euronext Paris , Business Wire , ஒன்றுபட்டது மாநிலங்களில் , தெற்கு கொரியா , வலேரியா மீனவர் , கேத்தரின் டேவிட் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , சந்தித்தல் ஆஃப் தி ஜப்பான் நீரிழிவு நோய் சமூகம் , ஆண்டு சந்தித்தல் , ஜப்பான் நீரிழிவு நோய் சமூகம் , நீண்டது கால கட்டம் ,

Poxel SA: Poxel Announces its Participation at the 64th Annual Meeting of the Japan Diabetes Society


Poxel SA: Poxel Announces its Participation at the 64th Annual Meeting of the Japan Diabetes Society
th Annual Meeting of the Japan Diabetes Society (May 20-22, 2021).
Three presentations on Imeglimin will be included in an oral session for large clinical studies in the afternoon (2:30 pm to 3:40 pm JST) of May 20. These presentations will be focused on the analysis and interpretation of clinical data derived from Phase 2 and Phase 3 (TIMES program) trials with Imeglimin, Poxel s novel antidiabetic investigational drug, where Japanese patients with type 2 diabetes (T2DM) were enrolled and studied:
TIMES 2: Long-term Phase 3 study with Imeglimin as a mono- and add-on therapies in Japanese T2DM ....

United States , South Korea , Sumitomo Dainippon Pharma , Arthur Rouill , Valeria Fisher , Catherine David , World Health Organization , Meeting Of The Japan Diabetes Society , Devices Agency , Trophic Communications , Annual Meeting , Japan Diabetes Society , Long Term Phase , Southeast Asian , Medical Devices Agency , Euronext Paris , Relations Communication Manager , Media France , ஒன்றுபட்டது மாநிலங்களில் , தெற்கு கொரியா , வலேரியா மீனவர் , கேத்தரின் டேவிட் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , சந்தித்தல் ஆஃப் தி ஜப்பான் நீரிழிவு நோய் சமூகம் , ஆண்டு சந்தித்தல் , ஜப்பான் நீரிழிவு நோய் சமூகம் ,